Charlas y Conferencias

CONFERENCIA EN LA UNIVERSIDAD NACIONAL DE ROSARIO

Todo lo que usted quiso saber sobre el Cannabis y nunca se atrevió a preguntar

FORO-DEBATE UNIVERSIDAD QUINTANA ROO

Todo lo que quiso saber acerca del Doctorado y nunca se atrevió a preguntar

CONFERENCIA UNAM

Papel del cannabidiol y sertralina para regular los cambios conductuales y de expresi¿n génica cerebral en un nuevo modelo animal de estrés postraumático

FORO IBEROAMERICANO

La pandemia COVID-19: mitos y realidades e impacto en la población

PONENCIA C.H.E.T. XOCHIMILCO

Vulnerabilidad por el consumo de alcohol en modelo animal de maltrato maternal y en adolescentes con consumo problemático. Un estudio traslacional.

PONENCIA HOSPITAL ESPECIALIZADO PARA ENFERMOS CRONICOS ACOLMAN

Papel del receptor cannabinoide CB2 en la regulación de procesos emocionales en modelos animales y suicidios

UMH

Utilidad terapéutica del cannabidiol en la dependencia por el consumo de alcohol

Leer Mas

Neurochemical and behavioral changes induced by maternal separation and vulnerability for alcohol consumption in mice

Cannabis: drug or medicine

Course in Advances in Drug Dependence

Center for Dementia, NYU Langone Medical Center, Department of Neurology, New York University, New York, USA (04/29/2015).

Therapeutic opportunities of cannabidiol in the treatment of neuropsychiatric diseases

Therapeutic opportunities of cannabidiol in the treatment of neuropsychiatric diseases

International Course of Translational Neuropsychopharmacology

Cannabis: drug or medicine

Course in Advances of Drug Treatment of Psychiatric Diseases

Course in Advances in Drug Dependence

Role of cannabinoid CB2 receptor in the regulation of emotional processes

UNP

Charla abierta relacionada al uso terapéutico del cannabis

Behavioral and neurobiological characterization induced by maternal deprivation and vulnerability for alcohol consumption in rodents

The role of cannabinoid CB2 receptor in the development of psychotic disorders and drug addiction

Course in Advances of Drug Treatment of Psychiatric Diseases

Discovery of the nicotine gene

Role of cannabinoid CB2 receptors in the regulation of anxiety and depression

Is the cannabinoid CB2 receptor a new target for neuropsychiatric diseases?

Cannabis: drug or medicine

Benefits or harms of the electronic cigarette from a neuropharmacological point of view

Is the cannabinoid CB2 receptor a new target for Alzheimer and Parkinson´s diseases?

Behavioral and neurobiological changes induced by maternal deprivation for alcohol consumption in adolescent mice

Role of cannabinoid CB2 receptor in the regulation of emotional processes

Role of CB2 cannabinoid receptor in psychiatric diseases and addictive disorders

Role of cannabinoid CB2 receptor in the reinforcement and motivation for nicotine consumption

Role of cannabinoid CB2 receptor in the reinforcement and motivation for alcohol and nicotine

Nicotine reinforcing effects and withdrawal syndrome

The cannabinoid system. A research area improving analgesia

Neurobiology of Cannabis dependence

Role of CB2 cannabinoid receptor in affective disorders

Interactions between the endogenous cannabinoid system and alcohol

Role of cannabinoid CB2 receptors in the development of psychiatric disorders and drug addiction with special focus on vulnerability to alcohol and nicotine consumption

The research in Addictive Disorders

The endogenous cannabinoid system: a new target in clinical neuroscience

Role of cannabinoid CB2 receptor in the reinforcement and motivation for cocaine consumption

Role of the CB2 cannabinoid receptor in the regulation of emotional behavior

Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB2 receptors

Role of CB2 cannabinoid receptor in psychiatric diseases

The opioid system and alcohol dependence

Role of cannabinoid CB2 receptor as a therapeutic target in anxiety and depression

Advances in the endogenous cannabinoid system

The endogenous cannabinoid system in alcohol dependence

Methods to evaluate behavior in mice

New pharmacological approaches to alcohol dependence

How important is the CB2 cannabinoid receptor in psychotic behavior?

Role of CB1 and CB2 cannabinoid receptors in Parkinson´s Disease

Role of topiramate and pregabalin in the regulation of spontaneous cannabinoid abstinence in rodents

New pharmacological treatments for cocaine and alcohol dependence

Role of CB2 cannabinoid receptor in the addiction to alcohol and cocaine

Role of cannabinoid CB2 receptor as therapeutic target in anxiety and depression

Role of CB2 receptor in neuropathic pain and depressive-like behavior

Role of cannabinoid CB2 receptor in the regulation of anxiety and depression

Role of topiramate and pregabalin in the regulation of spontaneous abstinence to cannabinoids in mice

Pharmacology of Parkinson´s Disease

Role of cannabinoid CB2 receptor as a therapeutic target in anxiety and depression

Presentation of SAFA Professor on Addiction

New pharmacological treatments for cocaine and alcohol dependence

Role of cannabinoid CB2 receptor as a new therapeutic target for the regulation of anxiety and depression

Advance in the endogenous cannabinoid system

Role of the cannabinoid CB1 receptor in the regulation of alcohol and benzodiazepine dependence

Genes and Addictive Disorders

Cannabinoid receptors in animal models of Parkinson´s Disease

Master Class

Presentation of the DISTEC Professor for education and research in Parkinson´s Disease

Role of the cannabinoid CB2 receptor in the regulation of anxiety and depression

The Addictive Disorder Spanish Network

Role of cannabinoid CB1 receptor in the regulation of anxiety

Neurodegenerative diseases and motor alterations

Presentation of the Translational Neuropsychopharmacology Unit of University Hospital of Albacete

Cannabis: Drug or medicament?

Advances in the treatment of diseases associated to consumption of cannabis

Cannabis: Drug or medicament?

Pharmaceutical Management in the National Health System

Role of dynorphin in the genetic vulnerability for alcohol consumption

Debate of the new Study Program of Pharmacy School

Long term effects of intracaudate administration of lactacystin on motor, emotional and cognitive behaviors and the expression of tyrosine hydroxylase in the basal ganglia

Anticonvulsant pharmacology and its relevance in addiction

Role of the cannabinoid CB1 receptor in development of dyskinesia

Strategies to prepare a research project and be successful

Genetic polymorphisms and CSF alterations in patients with Parkinson´s Disease

Role of opioid and cannabinoid systems in animal models of alcohol consumption

Cannabis: drug or medicament?

Cannabis: Drug or medicament?

Cannabis: Drug or medicament?

Role of cannabinoid CB1 receptor in abnormal movements induced in an animal model of Parkinson´s disease

Role of the cannabinoid CB1 receptor in the regulation of anxiety

Professional perspectives for Pharmacists

From brain homeostasis to the psychiatric disease

Opioid and cannabinoid systems in animal models of alcohol consumption

Opioid and cannabinoid systems as key vulnerability factors in ethanol preference

Cannabis: Drug or medicament?

Animal models of Parkinson´s Disease

Cannabis: Drug or medicament

Endogenous cannabinoid system and its functions in the brain

Role of the cannabinoid CB1 receptor in the vulnerability of the lesion by 6-OHDA

Cannabis as drug of abuse and as therapeutic agent

Role of opioid and cannabinoid systems in the vulnerability for alcohol consumption in animal models

Neurodegenerative diseases and motor alterations

Role of opioid and cannabinoid systems in the vulnerability for alcohol consumption

Presentation of Translational Neuropsychopharmacology Unit

Role of the CB1 cannabinoid receptor in Parkinson´s Disease

Animal models to study cognitive alterations

Pharmacology of the Rotigotine

Cannabis: Drug or medicament?

Role of the cannabinoid CB1 receptor in the vulnerability of the lesion by 6-OHDA

Cannabis: Drug or medicament

Psychobiology of Stress

Present situation of Cannabinoid research

Role of cannabinoid receptor in animal models of Parkinson Disease

Interaction between opioids and cannabinoids

Animal models in Psychiatry

Role of the endogenous cannabinoid CB1 receptor in the regulation of anxiety-related behaviors

Role of the cannabinoid CB1 receptor

Animal models of dual pathology

Role of the endogenous cannabinoid CB1

The integration between basic and clinical research

Endocannabinoid system

Relevance of neurotransmission and neuromodulation in psychiatry

Interactions between the opioid and the cannabinoid systems

Molecular alterations in psychiatric diseases

Animal models of psychiatric diseases

Impact of animal research in psychiatry

Animal models in Psychiatry

General overview on the present and future of Parkinson´s disease

Spontaneous abstinence to cannabinoids.

Pharmacological actions of the cannabinoid receptor antagonist AM251

Role of endogenous opioids in drug dependence

Physiological and therapeutic applications of cannabinoid receptors

Role of endogenous opioid system in addictive disorders

Cannabinoid interactions with the endogenous opioid system

Preclinical pharmacologic research

Pain perception and control

Role of the cannabinoid and opioid system in neuropsychiatry

Research in Psychiatry

Neurobiological bases of addictive disorders

Drugs used in diseases associated to stress

Pharmacologic and biochemical interactions

Opioid System and Addictions

Serotonin receptors and ligands

Interactions between cannabinoids and opioids

Drugs used in diseases associated to stress

Role of sexual hormones and cannabinoids in the regulation of proenkephalin and proopiomelanocortin

Regulation of opioid genes by cannabinoids

Regulation of dopaminergic activity by opioids

Actions of digestive peptides in the brain

Central action of cannabinoids. Involvement of the opioid system

Potential applications of cannabinoids and its analogues

Short and Long-term psychopharmacological strategies

Experimental treatments. Course of Research for Residents in Psychiatry

Regulation of opioid gene expression by chronic treatment with cannabinoids

New agonists and antagonists of 5-HT1A receptor in the treatment of affective states

Pharmacological characterization of B-20991, a 5-HT1A

Molecular biology in psychopharmacology

New agonists and antagonists of 5-HT1A receptor

Kappa opioid receptor regulation of nigrostriatal

Effects of opioid receptor

Tonic inhibitory action of kappa

Kappa-opioid mediated regulation

Effects of haloperidol